World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
25427
World Ranking
987
National Ranking
450

Medicine

D-Index
85
Citations
26305
World Ranking
14620
National Ranking
7395

Overview

John R. Graybill is affiliated with The University of Texas Health Science Center at San Antonio in the United States. Their research primarily focuses on the field of Medicine, with three publications attributed to this area.

The scientist's subfields of study include Epidemiology, with two publications, and Infectious Diseases, with one publication. These specialties provide a foundation for their work in clinical and public health contexts.

The main topics addressed in their research encompass fungal infections and studies, antifungal resistance and susceptibility, and nail diseases and treatments. Each of these topics is represented by two publications, highlighting a focused engagement with conditions involving fungal pathogens and associated therapeutic challenges.

  • Fungal Infections and Studies
  • Antifungal Resistance and Susceptibility
  • Nail Diseases and Treatments

Collaboratively, John R. Graybill has frequently co-authored with Gregory M. Anstead, with this partnership documented through one joint publication.

Best Publications

  • Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

    John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman

  • Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

    Thomas F. Patterson;William R. Kirkpatrick;Mary White;John W. Hiemenz

  • Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

    van der Horst Cm;Saag Ms;Cloud Ga;Hamill Rj

  • Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis

    J R Graybill;J Sobel;M Saag;C van Der Horst

  • NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis

    David W. Denning;David W. Denning;Jeanette Y. Lee;Jeanette Y. Lee;John S. Hostetler;John S. Hostetler;Peter Pappas;Peter Pappas

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes

    Qiu N. Sun;Annette W. Fothergill;Dora I. McCarthy;Michael G. Rinaldi;Michael G. Rinaldi

  • A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.

    W G Powderly;M S Saag;M S Saag;G A Cloud;G A Cloud;P Robinson;P Robinson

  • Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

    Issam I. Raad;Ray Y. Hachem;Raoul Herbrecht;John R. Graybill

  • In Vitro Activity of Caspofungin against Candida albicans Biofilms

    Stefano P. Bachmann;Kacy VandeWalle;Gordon Ramage;Thomas F. Patterson

  • Pharmacokinetics of itraconazole following oral administration to normal volunteers.

    T C Hardin;J R Graybill;R Fetchick;R Woestenborghs

  • Activity of posaconazole in the treatment of central nervous system fungal infections

    Punnee Pitisuttithum;Ricardo Negroni;John R. Graybill;Beatriz Bustamante

  • A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS-Associated Cryptococcal Meningitis

    Michael S. Saag;Gretchen A. Cloud;J. Richard Graybill;Jack D. Sobel

  • Treatment of murine cryptococcosis with liposome-associated amphotericin B.

    John R. Graybill;Philip C. Craven;Robert L. Taylor;Dwight M. Williams

  • Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.

    Issam I. Raad;John R. Graybill;Ana Beatriz Bustamante;Oliver A. Cornely

  • Voriconazole in the treatment of fungal eye infections: a review of current literature

    Unknown

  • Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.

    Robert A. Cramer;Michael P. Gamcsik;Rhea M. Brooking;Laura K. Najvar

  • High-Dose Ketoconazole Therapy and Adrenal and Testicular Function in Humans

    A. Pont;J.R. Graybill;P.C. Craven;J.N. Galgiani

  • In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model.

    Qiu N. Sun;Laura K. Najvar;Rosie Bocanegra;David Loebenberg

  • Fluconazole Therapy for Coccidioidal Meningitis

    John N. Galgiani;Antonino Catanzaro;Gretchen A. Cloud;Jean Higgs

  • Itraconazole treatment of phaeohyphomycosis.

    Patricia Kay Sharkey;John R. Graybill;Michael G. Rinaldi;David A. Stevens

  • Amphotericin B Lipid Complex Compared with Amphotericin B in the Treatment of Cryptococcal Meningitis in Patients with AIDS

    Patricia K. Sharkey;John R. Graybill;Edward S. Johnson;Stephen G. Hausrath

Frequent Co-Authors

Laura K. Najvar
Laura K. Najvar The University of Texas Health Science Center at San Antonio
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
David A. Stevens
David A. Stevens Stanford University
Thomas F. Patterson
Thomas F. Patterson The University of Texas Health Science Center at San Antonio
Nathan P. Wiederhold
Nathan P. Wiederhold The University of Texas Health Science Center at San Antonio
William E. Dismukes
William E. Dismukes University of Alabama at Birmingham
John N. Galgiani
John N. Galgiani University of Arizona
John R. Perfect
John R. Perfect Duke University
Annette W. Fothergill
Annette W. Fothergill The University of Texas Health Science Center at San Antonio
David W. Denning
David W. Denning University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology can open doors to diverse career options, many of which offer flexible online degree opportunities. For those interested in healthcare, pursuing medical degrees online allows students to gain essential skills while balancing other commitments. These programs often serve as a strong foundation for careers in biomedical research or clinical microbiology.

Public health is another complementary field, with several accessible programs designed for quick entry. Students seeking to advance their knowledge efficiently should consider the fastest and easiest online MPH programs. These degrees emphasize population health and epidemiology, which are closely linked to microbiological studies.

For those interested in applied healthcare roles supporting children and families, becoming a child life specialist is a meaningful career path. This role combines science understanding with emotional support, making it a unique option alongside microbiology-related fields.

Importantly, online education offers inclusive opportunities for many learners. There are online colleges that accept felons, opening pathways for individuals seeking second chances through education. These programs can lead to careers in various scientific and healthcare domains, highlighting the accessibility of microbiology and related degrees.

Best Scientists Citing John R. Graybill

Trending Scientists